Literature DB >> 20559649

Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?

Gehan A El-Shennawy1, Abd-Alla A Elbialy, Anwar E Isamil, Manal M El Behery.   

Abstract

INTRODUCTION: Uterine leiomyoma is the most common benign smooth muscle tumor.
OBJECTIVE: This study was carried out to evaluate the association of ER-α, CYP1A1, and CYP1B1 polymorphisms with uterine leiomyoma in Egyptian women.
METHODS: The study population consisted of 160 patients with uterine leiomyoma and 100 healthy women as control. The genetic polymorphisms for ER-α MSP1 exon 1, CYP1B1 Leu432Val, and CYP1A1 Ile462Val were analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing methods.
RESULTS: There were no statistically significant differences in the overall associations between the ER-α exon I CT genotypes and uterine leiomyoma (P = 0.47). However, an elevated risk of uterine leiomyoma was observed among women with the CYP1A1 Ile462Val AG genotype (P = 0.07) and CYP1B1 Leu 432Val C/C genotype (P = 0.08).
CONCLUSION: We concluded that the carriage of CYP1A1 Ile462Val AG and CYP1B1 Leu 432Val CC genotypes predict the susceptibility to leiomyoma in Egyptian women and they are likely to contribute in the pathogenesis of leiomyoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559649     DOI: 10.1007/s00404-010-1550-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  The associations between the polymorphisms of the ER-α gene and the risk of uterine leiomyoma (ULM).

Authors:  Yi Feng; Xiaojuan Lin; Shengtao Zhou; Ning Xu; Tao Yi; Xia Zhao
Journal:  Tumour Biol       Date:  2013-06-09

2.  CYP1A1 genetic polymorphisms and uterine leiomyoma risk: a meta-analysis.

Authors:  Fen Wang; Jiying Chen; Lin Wang; Yulan Ma; Niyazi Mayinuer
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

4.  Association of polymorphisms and haplotypes in the cytochrome P450 1B1 gene with uterine leiomyoma: A case control study.

Authors:  Saeedeh Salimi; Maryam Khodamian; Mehrnaz Narooie-Nejad; Azam Hajizadeh; Kimia Fazeli; Lida Namazi; Minoo Yaghmaei
Journal:  Biomed Rep       Date:  2014-12-31

5.  Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.

Authors:  Saeedeh Salimi; Mojtaba Sajadian; Maryam Khodamian; Atefeh Yazdi; Soodabeh Rezaee; Abbas Mohammadpour-Gharehbagh; Mojgan Mokhtari; Minoo Yaghmaie
Journal:  Bosn J Basic Med Sci       Date:  2016-06-22       Impact factor: 3.363

6.  Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Authors:  Qiwei Yang; Archana Laknaur; Lelyand Elam; Nahed Ismail; Larisa Gavrilova-Jordan; John Lue; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-03-31       Impact factor: 3.060

7.  Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

Authors:  William H Catherino; Heba M Eltoukhi; Ayman Al-Hendy
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303

Review 8.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

9.  Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections.

Authors:  L Amanti; H Sadeghi-Bazargani; H Abdollahi; F Ehdaeivand
Journal:  Int J Gen Med       Date:  2011-07-14

10.  Lack of Association between ESR1 and CYP1A1 Gene Polymorphisms and Susceptibility to Uterine Leiomyoma in Female Patients of Iranian Descent.

Authors:  Fatemeh Taghizade Mortezaee; Mohammad Amin Tabatabaiefar; Morteza Hashemzadeh Chaleshtori; Sepideh Miraj
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.